Trials / Completed
CompletedNCT03199794
Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study addresses the safety, utilisation and effectiveness of Obizur in the treatment of bleeding episodes in real-life clinical practice in Europe and the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OBIZUR | Treating physician will determine treatment regimen and frequency of laboratory and clinical assessments according to routine clinical practice. |
Timeline
- Start date
- 2016-12-14
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
- First posted
- 2017-06-27
- Last updated
- 2022-07-21
Locations
26 sites across 7 countries: United States, Austria, France, Germany, Italy, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT03199794. Inclusion in this directory is not an endorsement.